← ANALYSTS · TIPRANKS

Laura Chico · Wedbush

#527among 12,504 TipRanks analysts★★★★★★★★★★
Hits 54% 267 of 499 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +14.2% Over a year after the rating, TipRanks’ measure
Our companies rated now 25 Buy / hold / sell: 19 / 5 / 1
Upside of the analyst’s targets +96.4% Average over 25 current targets, to the last price
The market’s answer to the ratings +2.0% Day-0 move against SPY in the rating’s direction, average over 14 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 8on TipRanks 08:35 OVIDIWMOvid Therapeutics · $428M Reiterated Buy $7.00 +225.6% −0.4%next day +4.5% · 5 days −3.1%
Oct 5on TipRanks 07:07 KRSAKorsana Biosciences · $1.4B Initiated Buy $44.00 +35.9% +0.1%next day +2.9% · 5 days +10.4%
Sep 23on TipRanks 09:08 EWTXIWMEdgewise Therapeutics · $4.1B Reiterated Buy $53.00 +42.5% −7.1%next day +0.4% · 5 days −0.4%
Sep 23on TipRanks 09:08 MAZEIWMMaze Therapeutics, Inc. · $1.5B Reiterated Buy $48.00 +74.4% −0.3%next day −6.6% · 5 days −2.6%
Sep 22on TipRanks 08:55 TVTXIWMTravere Therapeutics · $5.0B Reiterated Buy $75.00 → $76.00+1.3% +53.2% −4.1%next day 0.0% · 5 days +0.7%
Sep 18on TipRanks 07:50 XENEIWMXenon · $3.3B Reiterated Buy $71.00 → $55.00−22.5% +64.2% −30.8%next day −3.5% · 5 days −8.3%
Sep 18on TipRanks 07:50 RAREIWMUltragenyx Pharmaceutical · $1.5B Reiterated Hold $23.00 +58.2% −0.1%next day −0.6% · 5 days −1.3%
Sep 16on TipRanks 08:09 VERAIWMVera Therapeutics · $2.1B Reiterated Hold $34.00 +22.0% −5.2%next day +6.7% · 5 days +2.0%
Sep 15on TipRanks 08:08 SIONIWMSionna Therapeutics, Inc. · $184M Reiterated Hold $5.00 → $6.00+20.0% +54.2% −16.2%next day +2.8% · 5 days −14.9%
Sep 9on TipRanks 08:50 PHVSPharvaris · $2.1B Reiterated Buy $42.00 → $50.00+19.0% +80.2% +0.2%next day 0.0% · 5 days +0.6%
Aug 19on TipRanks 08:55 CLYMIWMClimb Bio · $627M Reiterated Buy $20.00 +103.7% −0.5%next day −1.0% · 5 days −6.9%
Aug 18on TipRanks 06:05 ARDXIWMArdelyx · $795M Reiterated Buy $9.00 +191.3% −2.8%next day +2.6% · 5 days −3.4%
Aug 11on TipRanks 07:55 JBIOIWMJade Biosciences · $855M Reiterated Buy $45.00 → $47.00+4.4% +248.9% +3.2%next day +3.6% · 5 days +5.8%
Aug 6on TipRanks 08:50 BCRXIWMBioCryst · $2.0B Reiterated Buy $20.00 +156.7% +2.7%next day +0.2% · 5 days +4.3%
Aug 6on TipRanks Aug 4 17:15 VRDNIWMViridian Therapeutics · $2.2B Reiterated Buy $43.00 → $41.00−4.7% +115.4% +1.3%next day +7.0% · 5 days +8.2%
Aug 5on TipRanks 08:10 LRMRIWMLarimar Therapeutics · $207M Reiterated Buy $12.00 → $11.00−8.3% +454.2% 0.0%next day +2.6% · 5 days +6.2%
Aug 5on TipRanks 08:10 DNTHIWMDianthus Therapeutics · $4.2B Reiterated Buy $105 → $122+16.2% +69.2% +2.1%next day −2.1% · 5 days −0.4%
Aug 3on TipRanks 08:25 NBIXNeurocrine · $13.9B Reiterated Buy $185 → $194+4.9% +43.0% −1.8%next day −1.9% · 5 days −2.8%
Jul 31on TipRanks Jul 29 10:43 BIIBSPYBiogen · $34.8B Reiterated Hold $215 −7.6% +3.3%next day −2.3% · 5 days −6.8%
Jul 13on TipRanks 08:10 DNLIIWMDenali Therapeutics · $2.9B Reiterated Buy $20.00 → $26.00+30.0% +47.6% +3.9%next day −14.8% · 5 days −12.6%
Jun 2on TipRanks 07:55 PRAXIWMPraxis Precision Medicines · $6.9B Reiterated Sell $166 → $162−2.4% −33.0% −23.1%next day +8.8% · 5 days 0.0%
May 18on TipRanks May 13 08:35 SLDBIWMSolid Biosciences · $615M Reiterated Buy $16.00 +189.3% −5.0%next day +2.6% · 5 days −12.2%
May 14on TipRanks 21:30 ANROIWMAlto Neuroscience, Inc. · $888M Reiterated Hold $21.00 → $24.00+14.3% +9.4% −1.4%next day −5.1% · 5 days −8.5%
May 13on TipRanks 08:35 PEPGPepGen Inc. · $166M Reiterated Buy $5.00 → $4.00−20.0% +53.8% +5.4%next day −8.1% · 5 days −19.0%
May 8on TipRanks 08:40 STOKIWMStoke Therapeutics · $1.6B Reiterated Buy $38.00 +57.2% −0.5%next day −1.0% · 5 days −8.8%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗